MPG.eBooks - Description: Vaginal micronized progesterone capsules for the prevention of miscarriage and preterm birth

Cover Image

Read Now

Vaginal micronized progesterone capsules for the prevention of miscarriage and preterm birth a review of the clinical evidence

The purpose of this report is to review the available evidence on the clinical efficacy and safety of vaginally administered micronized progesterone capsules for the prevention of miscarriage and preterm birth

Bibliographic Details
Corporate Authors:	Canadian Agency for Drugs and Technologies in Health Rapid Response Service, Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	[Ottawa, Ontario] Canadian Agency for Drugs and Technologies in Health 2014, 28 April 2014
Series:	Rapid response report : summary with critical appraisal
Subjects:	Progesterone / Therapeutic Use Canada Premature Birth / Prevention & Control Abortion, Spontaneous / Prevention & Control Treatment Outcome Progesterone / Administration & Dosage Capsules
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK264073
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	The purpose of this report is to review the available evidence on the clinical efficacy and safety of vaginally administered micronized progesterone capsules for the prevention of miscarriage and preterm birth
Item Description:	Title from PDF caption title
Physical Description:	1 PDF file (18 pages) illustrations